XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Cost of revenue $ 10,953 $ 7,583 $ 28,978 $ 24,126
Gross profit 12,654 10,436 34,743 29,606
Operating expenses:        
Research and development 15,921 16,081 47,349 43,938
Selling, general and administrative 16,299 16,140 48,324 49,041
Total operating expenses 32,220 32,221 95,673 92,979
Loss from operations (13,982) (16,958) (43,992) (49,819)
Non-operating expense, net:        
Foreign exchange gain (loss) 490 (254) 540 (311)
Interest expense (930) (1,031) (2,794) (5,105)
Other income, net 351 336 962 1,095
Total non-operating expense, net (89) (949) (1,292) (4,321)
Loss before income taxes (14,071) (17,907) (45,284) (54,140)
Provision for income taxes 68 60 192 181
Net loss $ (14,139) $ (17,967) $ (45,476) $ (54,321)
Net loss per share:        
Basic and diluted $ (0.08) $ (0.13) $ (0.28) $ (0.39)
Weighted average shares used for calculating net loss per share:        
Basic and diluted 166,572 140,908 162,800 138,779
Product        
Revenue $ 23,607 $ 18,019 $ 63,721 $ 53,732
Government Contract        
Revenue $ 5,584 $ 4,827 $ 16,938 $ 13,554